Sergio Traversa, Chief Executive Officer at RELMADA THERAPEUTICS, INC. (RLMD), bought 395,431 shares at $0.67 ($265K) on 2025-08-27, disclosed to the SEC on 2025-08-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.62 | 80,545 | $50K | 18.9% |
| 2 | $0.67 | 129,455 | $87K | 32.8% |
| 3 | $0.67 | 129,455 | $87K | 32.8% |
| 4 | $0.74 | 55,976 | $41K | 15.6% |
| Total | $0.67 avg | 395,431 | $265K | 100% |
| Filing → |
| RLMD | BUY | 2025-11-06 | $600K | — | Filing → |
| RLMD | BUY | 2025-05-20 | $335K | — | Filing → |
| RLMD | BUY | 2024-09-11 | $790K | — | Filing → |